Newsroom

Categories: Biotechnology, Drug Discovery & Development, Pharma, Clinical Diagnostics

Aptamer Group introduces novel biomarker discovery service

August 28, 2025

Categories: Omics & Genetics, Biotechnology

Alithea Genomics announces the launch of MERCURIUS™ FLASH-seq: a plate-based, full-length single cell RNA-seq kit delivering exceptional sensitivity and simplicity

June 24, 2025

Categories: Omics & Genetics, Biotechnology

Alithea Genomics launches MERCURIUS™ Total DRUG-seq: a next-generation full-length transcriptome profiling platform for high-throughput compound screening and target validation

June 19, 2025

Categories: Biotechnology, Drug Discovery & Development

EpiCypher launches novel, affordable DNA methylation sequencing assays to accelerate drug discovery

April 24, 2025

Categories: Biotechnology, Life Science

ONTOFORCE’s DISQOVER chosen by The Michael J. Fox Foundation to enhance the integration and access of Parkinson’s disease research data

April 3, 2025

Categories: Bioprocessing, Biotechnology, Corporate, Finance & Investor

Abselion raises £6.6 million led by M Ventures to bring disruptive at-line protein analyser, Amperia, to market

December 4, 2024

Categories: Biotechnology, Clinical Research & Trials

Duke Street Bio announces first patient dosed in Phase I trial with DSB2455, a next deneration PARP1 selective inhibitor for the treatment of solid tumours

December 3, 2024

Categories: Biotechnology, Research, Life Science

Takara Bio Europe unveils new large-scale NGS profiling system and chemistries

September 26, 2024

Categories: Biotechnology, Clinical Research & Trials

Duke Street Bio granted approval by European Medicines Agency to launch next-generation PARP1-selective inhibitor trial

September 24, 2024